Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $3.38 million. The enterprise value is $46.47 million.
Important Dates
The last earnings date was Tuesday, April 7, 2026, before market open.
| Earnings Date | Apr 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 14.04 million shares outstanding. The number of shares has increased by 691.90% in one year.
| Current Share Class | 14.04M |
| Shares Outstanding | 14.04M |
| Shares Change (YoY) | +691.90% |
| Shares Change (QoQ) | +250.21% |
| Owned by Insiders (%) | 6.62% |
| Owned by Institutions (%) | 3.80% |
| Float | 13.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| Forward PS | 0.21 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.50
| Current Ratio | 0.50 |
| Quick Ratio | 0.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -673.25 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -61.46% |
| Return on Invested Capital (ROIC) | -80.07% |
| Return on Capital Employed (ROCE) | 1,935.14% |
| Weighted Average Cost of Capital (WACC) | 0.58% |
| Revenue Per Employee | $244,915 |
| Profits Per Employee | -$1.14M |
| Employee Count | 47 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 0.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.79% in the last 52 weeks. The beta is 0.29, so Jaguar Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -97.79% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 1.34 |
| Relative Strength Index (RSI) | 26.10 |
| Average Volume (20 Days) | 611,009 |
Short Selling Information
The latest short interest is 599,897, so 4.27% of the outstanding shares have been sold short.
| Short Interest | 599,897 |
| Short Previous Month | 481,255 |
| Short % of Shares Out | 4.27% |
| Short % of Float | 4.57% |
| Short Ratio (days to cover) | 1.21 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $11.51 million and -$53.58 million in losses. Loss per share was -$22.97.
| Revenue | 11.51M |
| Gross Profit | 7.74M |
| Operating Income | -45.11M |
| Pretax Income | -54.00M |
| Net Income | -53.58M |
| EBITDA | -43.20M |
| EBIT | -45.11M |
| Loss Per Share | -$22.97 |
Full Income StatementBalance Sheet
The company has $968,000 in cash and $43.61 million in debt, with a net cash position of -$42.64 million or -$3.04 per share.
| Cash & Cash Equivalents | 968,000 |
| Total Debt | 43.61M |
| Net Cash | -42.64M |
| Net Cash Per Share | -$3.04 |
| Equity (Book Value) | -18.69M |
| Book Value Per Share | -2.83 |
| Working Capital | -20.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.69 million and capital expenditures -$41,000, giving a free cash flow of -$23.73 million.
| Operating Cash Flow | -23.69M |
| Capital Expenditures | -41,000 |
| Depreciation & Amortization | 1.91M |
| Net Borrowing | 12.69M |
| Free Cash Flow | -23.73M |
| FCF Per Share | -$1.69 |
Full Cash Flow StatementMargins
| Gross Margin | 67.21% |
| Operating Margin | -391.87% |
| Pretax Margin | -469.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Jaguar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -691.90% |
| Shareholder Yield | -691.90% |
| Earnings Yield | -1,397.00% |
| FCF Yield | -618.69% |
Analyst Forecast
The average price target for Jaguar Health is $60.00, which is 24,796.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.00 |
| Price Target Difference | 24,796.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
Jaguar Health has an Altman Z-Score of -18.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.77 |
| Piotroski F-Score | 3 |
